Results 21 to 30 of about 10,730 (111)

Lung Transplantation and the Era of the Sensitized Patient

Frontiers in Immunology, 2021
Long term outcomes in lung transplant are limited by the development of chronic lung allograft dysfunction (CLAD). Within the past several decades, antibody-mediated rejection (AMR) has been recognized as a risk factor for CLAD.
Katherine A. Young, Hakim A. Ali, Kristi J. Beermann, John M. Reynolds, Laurie D. Snyder   +4 more
doaj   +1 more source

Medical Complications of Lung Transplantation

Journal of Chest Surgery, 2022
Lung transplantation (LT) is now considered as an effective treatment option for end-stage lung diseases that improves the short and long-term survival rates and quality of life.
Moo Suk Park
doaj   +1 more source

Acute fibrinous and organising pneumonia following lung transplantation is associated with severe allograft dysfunction and poor outcome: a case series

Pneumonia, 2015
  Acute fibrinous and organising pneumonia (AFOP) is a histopathologic variant of acute lung injury that has been associated with infection and inflammatory disorders and has been reported as a complication of lung transplantation.
Keith Meyer, Jennifer Bierach, Jeffrey Kanne, Jose Torrealba, Nilto De Oliveira   +4 more
doaj   +1 more source

Adherence is associated with a favorable outcome after lung transplantation.

PLoS ONE, 2019
Non-adherence to therapy is associated with impaired outcome in solid organ allograft recipients. Outcome data are limited after lung transplantation. In a single-center cohort study, adherence was assessed in 427 patients undergoing lung transplantation
Anna Bertram, Jan Fuge, Hendrik Suhling, Igor Tudorache, Axel Haverich, Tobias Welte, Jens Gottlieb   +6 more
doaj   +1 more source

Myeloid-Derived Suppressor Cells Are Increased in Lung Transplant Recipients and Regulated by Immunosuppressive Therapy

Frontiers in Immunology, 2022
Lung transplantation remains as a primary treatment for end-stage lung diseases. Although remarkable improvement has been achieved due to the immunosuppressive protocols, long-term survival for lung transplant recipients (LTR) is still limited.
María Iglesias-Escudero, María Iglesias-Escudero, David San Segundo, David San Segundo, David Merino-Fernandez, Victor M. Mora-Cuesta, Patricia Lamadrid, Marta Alonso-Peña, Sandra Raso, David Iturbe, Sonia Fernandez-Rozas, Jose Cifrian, Marcos López-Hoyos, Marcos López-Hoyos, Marcos López-Hoyos   +14 more
doaj   +1 more source

Outcomes Following ATG Therapy for Chronic Lung Allograft Dysfunction

Transplantation Direct, 2021
Background. Chronic lung allograft dysfunction (CLAD) is the major factor limiting survival post lung transplantation (LTx) with limited effective therapeutic options.
Sakhee Kotecha, FRACP, Eldho Paul, BS, MS, Steve Ivulich, MPharm, Jeremy Fuller, BS, Miranda Paraskeva, FRACP, Bronwyn Levvey, RN, Gregory Snell, MD, FRACP, Glen Westall, PhD, FRACP   +7 more
doaj   +1 more source

Coronavirus infection and chronic lung allograft dysfunction: a retrospective cohort study

Swiss Medical Weekly
INTRODUCTION: Long-term survival in lung transplant recipients is limited by chronic lung allograft dysfunction, which can be triggered by respiratory tract infections. STUDY AIMS: We investigated the incidence of chronic lung allograft dysfunction in
Lydia Canham, Carolin Steinack, René Hage, Maurice Roeder, Silvia Ulrich, Gernot Ortmanns, Silvan Vesenbeckh, Thomas Gaisl, Macé M. Schuurmans   +8 more
doaj   +1 more source

Using a combination of biomarkers to monitor allograft dysfunction in lung transplant recipients

Frontiers in Transplantation
Allograft dysfunction is a major limitation of survival in organ transplant recipients including those who have received lung transplantation. Early detection of allograft dysfunction is thus crucial to improve outcomes in these patients.
Zein Kattih, Shambhu Aryal
doaj   +1 more source

Thoracic Ultrasound in Lung Transplantation—Insights in the Field

Life, 2023
The use of thoracic ultrasound (TUS) is a novel and dynamic diagnostic and monitoring modality that has shown remarkable advances within the last decade, with several published papers investigating its role within the field of lung transplantation.
Hans Henrik Lawaetz Schultz, Jesper Rømhild Davidsen   +1 more
doaj   +1 more source

Humoral immune responses mediate the development of a restrictive phenotype of chronic lung allograft dysfunction

JCI Insight, 2020
Understanding the distinct pathogenic mechanisms that culminate in allograft fibrosis and chronic graft failure is key in improving outcomes after solid organ transplantation.
Keizo Misumi, David S. Wheeler, Yoshiro Aoki, Michael P. Combs, Russell R. Braeuer, Ryuji Higashikubo, Wenjun Li, Daniel Kreisel, Ragini Vittal, Jeffrey Myers, Amir Lagstein, Natalie M. Walker, Carol F. Farver, Vibha N. Lama   +13 more
doaj   +1 more source